Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Skinvisible (SKVI) EBIT Margin (2016 - 2025)

Skinvisible (SKVI) has disclosed EBIT Margin for 16 consecutive years, with 2283.38% as the latest value for Q4 2025.

  • Quarterly EBIT Margin rose 169148.0% to 2283.38% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 2481.57% through Dec 2025, up 46637.0% year-over-year, with the annual reading at 2481.57% for FY2025, 46637.0% up from the prior year.
  • EBIT Margin hit 2283.38% in Q4 2025 for Skinvisible, down from 2121.14% in the prior quarter.
  • In the past five years, EBIT Margin ranged from a high of 58.35% in Q4 2021 to a low of 3974.86% in Q4 2024.
  • Historically, EBIT Margin has averaged 1807.54% across 5 years, with a median of 2272.79% in 2023.
  • Biggest five-year swings in EBIT Margin: soared 282876bps in 2021 and later plummeted -242547bps in 2023.
  • Year by year, EBIT Margin stood at 58.35% in 2021, then tumbled by -4135bps to 2354.32% in 2022, then fell by -16bps to 2730.76% in 2023, then tumbled by -46bps to 3974.86% in 2024, then surged by 43bps to 2283.38% in 2025.
  • Business Quant data shows EBIT Margin for SKVI at 2283.38% in Q4 2025, 2121.14% in Q3 2025, and 2724.74% in Q2 2025.